Cargando…

SPAG9 Expression Predicts Good Prognosis in Patients with Clear-Cell Renal Cell Carcinoma: A Bioinformatics Analysis with Experimental Validation

Clear-cell renal cell carcinoma (ccRCC) is the most common and aggressive type of renal-cell carcinoma (RCC). Sperm-associated antigen 9 (SPAG9) has been reported to promote the progression of a variety of tumors and is thus a potential prognostic marker. This study combined a bioinformatics analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Liwen, Zhang, Lu, Wang, Huiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138117/ https://www.ncbi.nlm.nih.gov/pubmed/37107702 http://dx.doi.org/10.3390/genes14040944

Ejemplares similares

Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma
por: Shen, Junlin, et al.
Publicado: (2023)

MicroRNA‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma
por: Nofech‐Mozes, Roy, et al.
Publicado: (2016)

Decreased Expression of GLYATL1 Predicts Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma
por: Deng, Limin, et al.
Publicado: (2023)

Construction and validation of a seven-gene signature for predicting overall survival in patients with kidney renal clear cell carcinoma via an integrated bioinformatics analysis
por: Jiang, Huiming, et al.
Publicado: (2020)

Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics
por: Wu, Hongrong, et al.
Publicado: (2021)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma
por: Peng, Qiang, et al.
Publicado: (2019)

Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis
por: Zhang, Ning, et al.
Publicado: (2020)

A Ferroptosis-Related Genes Model Allows for Prognosis and Treatment Stratification of Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis and Experimental Verification
por: Wu, Jiyue, et al.
Publicado: (2022)

Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification
por: Zhang, Yinglang, et al.
Publicado: (2021)

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
por: Zhu, Wenbiao, et al.
Publicado: (2021)

Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation
por: Zou, Xiong, et al.
Publicado: (2022)

Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation
por: Zhang, Xinyu, et al.
Publicado: (2022)

Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Huiming, et al.
Publicado: (2020)

miR-874 inhibits gastric cancer cell proliferation by targeting SPAG9
por: Sun, Qin Hui, et al.
Publicado: (2020)

FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis
por: Huang, Xing, et al.
Publicado: (2022)

Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma
por: Duan, Jiachen, et al.
Publicado: (2022)

Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Gao, Ruizhi, et al.
Publicado: (2021)

Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma
por: Deng, Yulin, et al.
Publicado: (2022)

Glycogen rich clear cell carcinoma of the breast: a rare subtype with good prognosis
por: Al-Musaifer, Budoor Mohamed, et al.
Publicado: (2019)

Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation
por: Gu, Yu, et al.
Publicado: (2022)

Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma
por: Wu, Song, et al.
Publicado: (2011)

Circulating large extracellular vesicles carrying CA9 in the diagnosis and prognosis of clear‐cell renal cell carcinoma
por: Vergori, Luisa, et al.
Publicado: (2021)

miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma
por: Ran, LongJiao, et al.
Publicado: (2017)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression
por: Yan, Qiuyue, et al.
Publicado: (2016)

Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
por: Xu, Dengyong, et al.
Publicado: (2020)

High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma
por: Niu, Haitao, et al.
Publicado: (2018)

Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma—a bioinformatics analysis
por: Zhao, Ya-Wei, et al.
Publicado: (2022)

Development and validation of a mitochondrial metabolism‐associated nomogram for prediction of prognosis in clear cell renal cell carcinoma
por: Zeng, Bohan, et al.
Publicado: (2020)

Identification and validation of a genetic risk signature associated with prognosis in clear-cell renal cell carcinoma patients
por: Lian, Meiqin, et al.
Publicado: (2023)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma
por: Luo, Ting, et al.
Publicado: (2018)

Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma
por: Wang, Jinxing, et al.
Publicado: (2018)

Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
por: Huang, Hao, et al.
Publicado: (2021)

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis
por: Wang, Qian, et al.
Publicado: (2019)

Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma
por: Pan, Ziwen, et al.
Publicado: (2022)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis in vitro
por: Chen, Feifei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i5rrea65tohuj382o82hdtjsk5